MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

AdvanDx Closes US$8 Million Financing Round and Elects New Board Member

18th August 2009 WOBURN, Massachusetts and VEDBAEK, Denmark, August 18 /PRNewswire/ -- AdvanDx today announced it has closed another US$8 million in financing from existing stockholders, SLS Venture and LD Pensions. The additional investment is part of a series C round of financing, the first part of which was closed in September 2007, and will be used to fund the expansion of AdvanDx's molecular diagnostics product offering as well as its international sales and marketing activities. In addition to the... more

Cappella Inc. Secures US$17.3 Million Series C Investment

15th June 2009 WILMINGTON, Delaware and GALWAY, Ireland, June 15 /PRNewswire/ -- more

Next-Generation U.S. Technologies Seek Middle Eastern, Global Investors

18th May 2009 NEW YORK, May 18 /PRNewswire/ -- The next generation of U.S. technologies - in energy, medical, aerospace and media - is now actively seeking Middle Eastern and other international investors. Representatives will be in the Gulf May 18-30 to meet interested partners. MHM/global strategy is helping a select group of future technology leaders find the right global partners. These public and private technology companies offer international investors the chance to "lead" rather than "follow"... more
Venture Capital RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

Next-Generation U.S. Technologies Seek Middle Eastern, Global Investors
10th May 2009 NEW YORK, May 10 /PRNewswire/ -- The next generation of U.S. technologies - in energy, medical, aerospace and media - is now actively seeking Middle Eastern and other international investors....

Merck Serono Launches Strategic Venture Capital Fund
23rd March 2009 GENEVA, Switzerland, March 23 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the formation of 'Merck Serono Ventures', a strategic, corporate venture...

Eiger BioPharmaceuticals Raises US$7.1 Million 'A' Round
24th February 2009 PALO ALTO, California, February 24 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised US$7.1 million in a...

E6 Ventures Wins Investment for Spin Out Company, Diamond Detectors
17th November 2008 ASCOT, England, November 17 /PRNewswire/ -- Diamond Detectors Ltd, a subsidiary company set up by Element Six to manufacture innovative diamond detectors and sensors for radiation...

Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels
25th August 2008 WELLESLEY HILLS, Massachusetts, August 25 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today...

ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
7th August 2008 ZURICH, Switzerland, August 7 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has raised an additional CHF 23M (USD 22M, EUR 14M)...

Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
29th April 2008 DUBLIN and NEW YORK, April 29 /PRNewswire/ -- Fountain Healthcare Partners ("Fountain") today launches and announces the first close of its inaugural fund, Fountain Healthcare Partners I, with EUR75...

Breathe Technologies, Inc. Closes on US$15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
26th March 2008 FREMONT, California, March 26 /PRNewswire/ -- Breathe Technologies, Inc., which is developing innovative, patient-friendly medical devices to treat respiratory problems associated with Chronic...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us